CATALOGO DEI PRODOTTI DELLA RICERCA

ADAMI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.786
NA - Nord America 3.854
AS - Asia 3.516
SA - Sud America 532
AF - Africa 109
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.807
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.756
RU - Federazione Russa 2.511
SG - Singapore 1.482
CN - Cina 1.006
GB - Regno Unito 562
BR - Brasile 451
IT - Italia 399
HK - Hong Kong 342
DE - Germania 329
SE - Svezia 239
FR - Francia 229
IE - Irlanda 219
VN - Vietnam 196
IN - India 148
KR - Corea 105
FI - Finlandia 97
JP - Giappone 64
CA - Canada 52
MX - Messico 36
PL - Polonia 35
NL - Olanda 33
BJ - Benin 30
AR - Argentina 29
BD - Bangladesh 29
TR - Turchia 29
ID - Indonesia 28
ZA - Sudafrica 28
TG - Togo 27
AT - Austria 26
ES - Italia 24
UA - Ucraina 20
IQ - Iraq 17
CO - Colombia 10
EC - Ecuador 10
UZ - Uzbekistan 9
VE - Venezuela 9
BE - Belgio 8
PK - Pakistan 8
IR - Iran 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
EG - Egitto 6
GR - Grecia 6
LT - Lituania 6
AU - Australia 5
AZ - Azerbaigian 5
CL - Cile 5
PE - Perù 5
PY - Paraguay 5
AL - Albania 4
CZ - Repubblica Ceca 4
IL - Israele 4
BO - Bolivia 3
ET - Etiopia 3
GE - Georgia 3
JO - Giordania 3
KE - Kenya 3
KG - Kirghizistan 3
KW - Kuwait 3
LV - Lettonia 3
MA - Marocco 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AM - Armenia 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HR - Croazia 2
ME - Montenegro 2
MK - Macedonia 2
MY - Malesia 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
A1 - Anonimo 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CD - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GF - Guiana Francese 1
GN - Guinea 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 12.801
Salva come PNG Salva come JPEG
Città #
Moscow 926
Singapore 677
Dallas 638
Chandler 488
Southend 448
Ashburn 417
Hong Kong 336
Dublin 214
Beijing 171
New York 122
Los Angeles 114
Jacksonville 101
The Dalles 95
Redmond 90
Wilmington 78
Lawrence 74
Princeton 74
Ho Chi Minh City 71
Bologna 68
Verona 65
Tokyo 63
Ann Arbor 61
Jinan 60
Munich 59
Helsinki 55
Shenyang 54
Buffalo 53
Redondo Beach 48
Hyderabad 47
Nanjing 46
Sindelfingen 46
São Paulo 46
Hanoi 40
London 40
Tianjin 39
Seattle 37
Woodbridge 35
Falkenstein 34
Hebei 34
Columbus 32
Santa Clara 32
Warsaw 32
Cotonou 30
Denver 30
Lomé 27
Washington 27
Zhengzhou 27
Brooklyn 26
Houston 24
Guangzhou 23
Hangzhou 23
Milan 23
Turku 23
Changsha 22
Taiyuan 22
Haikou 21
Montreal 21
Orem 21
San Francisco 20
Nanchang 19
Ningbo 19
Poplar 19
Rome 19
Johannesburg 18
Stockholm 18
Boston 16
Dongguan 16
Chicago 15
Fairfield 15
Jakarta 15
Jiaxing 15
Mexico City 15
Redwood City 15
Chennai 14
Taizhou 14
Atlanta 13
Manchester 13
Rio de Janeiro 13
Council Bluffs 12
Da Nang 11
Norwalk 11
Seoul 11
Venice 11
Vienna 11
Amsterdam 10
Brasília 10
Ankara 9
Miami 9
Phoenix 9
Tashkent 9
Belo Horizonte 8
Biên Hòa 8
Campinas 8
Falls Church 8
Fuzhou 8
Naples 8
Toronto 8
Brussels 7
Dearborn 7
Querétaro 7
Totale 7.171
Salva come PNG Salva come JPEG
Nome #
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 229
Anti-CCP antibodies and bone 209
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 194
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 188
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 184
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 173
Could γ\δ T-cells explain zoledronic acid adverse events? 169
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 169
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 169
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 167
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 165
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 161
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 160
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 159
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 157
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 152
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 148
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 146
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 144
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 144
Safety issues and adverse reactions with osteoporosis management 141
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 140
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 137
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 136
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 136
Association between environmental air pollution and rheumatoid arthritis flares 136
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 135
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 134
Association between acute exposure to environmental air pollution and fragility hip fractures 132
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 129
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 129
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 128
Calcium and vitamin D supplementation: when and why 128
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 127
A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study 126
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 124
Rheumatoid arthritis, γδ T cells and bisphosphonates 123
The obesity paradox and osteoporosis 123
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 123
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 122
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 122
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 119
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 118
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 117
Osteoporosis in Rheumatic Diseases 117
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 116
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 113
Correction to: The obesity paradox and osteoporosis 112
Gender disparity in authorship of guidelines and recommendations in rheumatology 111
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 110
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 110
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 110
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 109
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 109
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 108
A Prospective Open-Label Observational Study of a Buffered Soluble 70{\hspace{0.167em}}mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The {GastroPASS} Study 108
Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low-Dose Glucocorticoids and Prevention by Anti-Osteoporosis Medications 107
Changes in bone turnover markers and bone modulators during abatacept treatment 107
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 107
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 106
Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot study 102
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 101
Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial 101
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 100
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 100
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 96
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 95
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 95
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 95
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 95
Bone health status evaluation in men by means of REMS technology 91
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 91
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 87
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3 86
Balancing benefits and risks in the era of biologics 85
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 85
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 82
Response to: ‘Correspondence on ‘Gender disparity in authorship of guidelines and recommendations in rheumatology’’ by Stewart et al 82
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 81
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 80
Glucocorticoid-induced osteoporosis: 2019 concise clinical review 80
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 80
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 77
Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database 76
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis 76
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal 76
The role of 18FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature 74
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis 73
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 72
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 69
Machine learning to characterize bone biomarkers profile in rheumatoid arthritis 68
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 68
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 67
Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study 67
Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart 67
Cardiovascular Safety of Romosozumab: New Insights from Postmenopausal Women with Chronic Kidney Disease 66
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 66
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach 65
Long-Term Bone Mineral Density Changes in Kidney Transplant Recipients Treated with Denosumab: A Retrospective Study with Nonequivalent Control Group 65
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 63
Totale 11.477
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.485
article - articoli 49.219
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 219
patent - brevetti 0
selected - selezionate 0
volume - volumi 47
Totale 98.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021234 0 0 0 0 0 44 40 5 52 5 55 33
2021/2022579 59 129 8 20 30 21 15 34 56 20 27 160
2022/20231.499 88 151 118 286 127 345 15 68 170 36 74 21
2023/2024982 40 70 89 125 80 202 54 44 30 43 151 54
2024/20252.632 111 132 104 409 160 79 136 103 402 318 231 447
2025/20265.673 538 391 612 1.453 2.209 470 0 0 0 0 0 0
Totale 13.060